Close

BMO Capital Reiterates Outperform Following DAVIDsTEA Inc.'s (DTEA) In-Line 2Q

Go back to BMO Capital Reiterates Outperform Following DAVIDsTEA Inc.'s (DTEA) In-Line 2Q

Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)

September 8, 2016 9:29 AM EDT

Today's Pre-Open Movers

Repros Therapeutics Inc. (Nasdaq: RPRX) 31.9% HIGHER; provided posotive results of the first course of treatment from Repros ongoing study of Proellex® for the treatment of premenopausal women with confirmed symptomatic endometriosis.

Gevo, Inc. (Nasdaq: GEVO) 25.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions,... More

After-Hours Stock Movers 09/07: (RPRX) (JUNO) (ABEO) Higher; (GEVO) (TSCO) (PIR) Lower (more...)

September 7, 2016 6:07 PM EDT

Today's After-Hours Movers

Repros Therapeutics Inc. (Nasdaq: RPRX) 43.9% HIGHER; provided posotive results of the first course of treatment from Repros ongoing study of Proellex® for the treatment of premenopausal women with confirmed symptomatic endometriosis.

Gevo, Inc. (Nasdaq: GEVO) 17.2% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series E units, with each Series E unit consisting of one share of common stock and Series I... More

DAVIDsTEA Inc. (DTEA) Misses Q2 EPS by 2c, Offers Q3 Guidance

September 7, 2016 4:04 PM EDT

DAVIDsTEA Inc. (NASDAQ: DTEA) reported Q2 EPS of (CDN$0.09), CDN$0.02 worse than the analyst estimate of (CDN$0.07). Revenue for the quarter came in at CDN$41.1 million versus the consensus estimate of CDN$30.93 million.

comparable sales increase of... More